GeneDx Holdings Warrant
WGSWW
WGSWW was delisted on the 21st of July, 2026.
27 hedge funds and large institutions have $3.75M invested in GeneDx Holdings Warrant in 2022 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, 6 reducing their positions, and 1 closing their positions.
0% more funds holding
Funds holding: 27 → 27 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
33% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 6
39% less capital inflows, than outflows
Capital inflows: $39.9K | Capital outflows: $65.3K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$30.4K |
| 2 |
Old Mission Capital
Chicago,
Illinois
|
+$6.1K |
| 3 |
Gagnon Securities
New York
|
+$2.07K |
| 4 |
Wolverine Asset Management
Chicago,
Illinois
|
+$1.22K |
| 5 |
Jane Street
New York
|
+$42 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Aristeia Capital
Greenwich,
Connecticut
|
-$35K |
| 2 |
LMR Partners
London,
United Kingdom
|
-$13.7K |
| 3 |
AGM
Alpine Global Management
New York
|
-$7.83K |
| 4 |
Islet Management
New York
|
-$6.46K |
| 5 |
HRT Financial
New York
|
-$1.34K |
WGSWW Hedge Fund Activity: Q2 2022 in Review
27 of the 5,963 institutional investors tracked by Wall St. Rank reported a position in GeneDx Holdings Warrant (WGSWW) for Q2 2022, worth a combined $3.75M — down 57% from $8.79M a quarter earlier.
Fund positioning in WGSWW was balanced in Q2 2022: 1 fund opened new positions, 1 closed out, 4 added to existing stakes and 6 trimmed.
The largest buyer was UBS Group, adding an estimated $30.4K. The largest seller was Aristeia Capital, exiting entirely with an estimated $35K sold.
- 27 institutional investors held GeneDx Holdings Warrant (WGSWW) as of Q2 2022, unchanged from Q1 2022.
- Funds reported $3.75M of GeneDx Holdings Warrant stock for Q2 2022, down 57% quarter-over-quarter.
- 1 fund opened new GeneDx Holdings Warrant positions in Q2 2022 and 1 closed out, a net change of 0 holders.
- The largest GeneDx Holdings Warrant buyer in Q2 2022 was UBS Group, an estimated $30.4K added.
- The largest GeneDx Holdings Warrant seller in Q2 2022 was Aristeia Capital, an estimated $35K sold.
Based on aggregated 13F filings for Q2 2022.